Uwe Haberkorn


Ontology type: schema:Person     


Person Info

NAME

Uwe

SURNAME

Haberkorn

Publications in SciGraph latest 50 shown

  • 2019-05 Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing “the lead” into PSMA-targeted alpha therapy? in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-01-22 PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide in MOLECULAR IMAGING AND BIOLOGY
  • 2019-01 Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLT in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-12 Influence of 68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy in RADIATION ONCOLOGY
  • 2018-12 Feasibility and robustness of dynamic 18F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation in SCIENTIFIC REPORTS
  • 2018-12 Impact of Computer-Aided CT and PET Analysis on Non-invasive T Staging in Patients with Lung Cancer and Atelectasis in MOLECULAR IMAGING AND BIOLOGY
  • 2018-12 Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer in SCIENTIFIC REPORTS
  • 2018-12 Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy in SCIENTIFIC REPORTS
  • 2018-11 Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-10 Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-08 Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2018-08 Role of CT Density in PET/CT-Based Assessment of Lymphoma in MOLECULAR IMAGING AND BIOLOGY
  • 2018-07 Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-07 Warum braucht die Nephrologie heute noch die Nierenszintigraphie? in DER NEPHROLOGE
  • 2018-07 Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial in BRITISH JOURNAL OF CANCER
  • 2018-07 The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-07 Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-06 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-04 Correction to: Dosimetry in clinical radionuclide therapy: the devil is in the detail in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-03 Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-03 Simultaneous whole-body 18F–PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2018-01 Targeted alpha therapy of mCRPC: Dosimetry estimate of 213Bismuth-PSMA-617 in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-12 Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients in CANCER IMAGING
  • 2017-12 First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas in RADIATION ONCOLOGY
  • 2017-11 Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-11 Dosimetry in clinical radionuclide therapy: the devil is in the detail in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-09 Erratum to: Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-09 Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-09 Effects of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 (HBED-CC) PET/MRI in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-08 Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-06 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0 in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-06 Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095 in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-05 Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-04 F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-04 Radiomic Analysis using Density Threshold for FDG-PET/CT-Based N-Staging in Lung Cancer Patients in MOLECULAR IMAGING AND BIOLOGY
  • 2017 PET and SPECT in SMALL ANIMAL IMAGING
  • 2017-01 Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2017-01 Stellenwert der PSMA-Liganden-Bildgebung beim Prostatakarzinom in DER UROLOGE
  • 2017 Role of Radiolabelled Small Molecules Binding to PSMA in Diagnosis and Therapy of Prostate Cancer in PET/CT IN PROSTATE CANCER
  • 2016-12 Future trends in prostate cancer theranostics with PSMA ligands in CLINICAL AND TRANSLATIONAL IMAGING
  • 2016-09 18F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617 in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-08 Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-07 68Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-07 Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-06 18th European Symposium on Radiopharmacy and Radiopharmaceuticals in EJNMMI RADIOPHARMACY AND CHEMISTRY
  • 2016-04 A Comparison of microCT and microPET for Evaluating Lymph Node Metastasis in a Rat Model in MOLECULAR IMAGING AND BIOLOGY
  • 2016-03 High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-01 Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-01 68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-01 Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.5253.1", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412282.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7700.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.461820.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.488256.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411656.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411544.1", 
            "type": "Organization"
          }
        ], 
        "familyName": "Haberkorn", 
        "givenName": "Uwe", 
        "id": "sg:person.01142772466.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142772466.17"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_389.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01142772466.17'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01142772466.17'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01142772466.17'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01142772466.17'


     

    This table displays all metadata directly associated to this object as RDF triples.

    30 TRIPLES      10 PREDICATES      18 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01142772466.17 schema:affiliation N92d927f086c5437fbd0812766f32d5a1
    2 https://www.grid.ac/institutes/grid.411544.1
    3 https://www.grid.ac/institutes/grid.411656.1
    4 https://www.grid.ac/institutes/grid.412282.f
    5 https://www.grid.ac/institutes/grid.461820.9
    6 https://www.grid.ac/institutes/grid.488256.5
    7 https://www.grid.ac/institutes/grid.7497.d
    8 https://www.grid.ac/institutes/grid.7700.0
    9 schema:familyName Haberkorn
    10 schema:givenName Uwe
    11 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142772466.17
    12 schema:sdDatePublished 2019-03-07T14:38
    13 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    14 schema:sdPublisher Nb973137f20844ad38d35388b394d3f49
    15 sgo:license sg:explorer/license/
    16 sgo:sdDataset persons
    17 rdf:type schema:Person
    18 N92d927f086c5437fbd0812766f32d5a1 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
    19 sgo:isCurrent true
    20 rdf:type schema:OrganizationRole
    21 Nb973137f20844ad38d35388b394d3f49 schema:name Springer Nature - SN SciGraph project
    22 rdf:type schema:Organization
    23 https://www.grid.ac/institutes/grid.411544.1 schema:Organization
    24 https://www.grid.ac/institutes/grid.411656.1 schema:Organization
    25 https://www.grid.ac/institutes/grid.412282.f schema:Organization
    26 https://www.grid.ac/institutes/grid.461820.9 schema:Organization
    27 https://www.grid.ac/institutes/grid.488256.5 schema:Organization
    28 https://www.grid.ac/institutes/grid.5253.1 schema:Organization
    29 https://www.grid.ac/institutes/grid.7497.d schema:Organization
    30 https://www.grid.ac/institutes/grid.7700.0 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...